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Abstract
Background: Mating changes the mode of action of 17beta-estradiol (E2) to accelerate oviductal
egg transport from a nongenomic to a genomic mode, although in both pathways estrogen
receptors (ER) are required. This change was designated as intracellular path shifting (IPS).
Methods: Herein, we examined the subcellular distribution of ESR1 and ESR2 (formerly known as
ER-alpha and ER-beta) in oviductal epithelial cells of rats on day 1 of cycle (C1) or pregnancy (P1)
using immunoelectron microscopy for ESR1 and ESR2. The effect of mating on intraoviductal ESR1
or ESR2 signaling was then explored comparing the expression of E2-target genes c-fos, brain
creatine kinase (Ckb) and calbindin 9 kDa (s100g) in rats on C1 or P1 treated with selective
agonists for ESR1 (PPT) or ESR2 (DPN). The effect of ER agonists on egg transport was also
evaluated on C1 or P1 rats.
Results:  Receptor immunoreactivity was associated with the nucleus, cytoplasm and plasma
membrane of the epithelial cells. Mating affected the subcellular distribution of both receptors as
well as the response to E2. In C1 and P1 rats, PPT increased Ckb while both agonists increased c-
fos. DPN increased Ckb and s100g only in C1 and P1 rats, respectively. PPT accelerated egg
transport in both groups and DPN accelerated egg transport only in C1 rats.
Conclusion: Estrogen receptors present a subcellular distribution compatible with E2 genomic
and nongenomic signaling in the oviductal epithelial cells of C1 and P1 although IPS occurs
independently of changes in the distribution of ESR1 and ESR2 in the oviductal epithelial cells.
Mating affected intraoviductal ER-signaling and induced loss of functional involvement of ESR2 on
E2-induced accelerated egg transport. These findings reveal a profound influence on the ER
signaling pathways exerted by mating in the oviduct.
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Background
It is well recognized that in the female mammal ovarian
steroids, embryonic signals or mating-associated signals
regulate egg transport through the oviduct (for review see
[1]). In cyclic rats, oocytes reach the uterus approximately
72 h after ovulation, whereas in pregnant rats embryos
take 96 h. Oocytes take 96 h to traverse the oviduct in rats
made pseudopregnant by mechanical stimulation of the
cervix in the evening of proestrus, therefore the above dif-
ference is dependent on mating-associated signals rather
on whether eggs are fertilized or not [2]. Eggs cross the
ampullary-isthmic junction 9 h earlier and egg surrogates
move at higher speed in the isthmic segment with most of
them arriving earlier to the intramural segment in preg-
nant rats than in cycling rats [3]. Thus, a broad change
occurs in oviductal functioning elicited by mating-associ-
ated signals.
A single injection of 17β-estradiol (E2) on day 1 of the
cycle or pregnancy shortens oviductal transport of eggs
from the normal 72-96 h to less 24 h [1]. Previously, we
demonstrated that inhibitors of RNA and protein synthe-
sis block E2-induced oviductal embryo transport accelera-
tion in pregnant rats, but fail to do so in cyclic rats [4,5].
Furthermore, in cyclic rats exogenous E2 activates protein
phosphorylation in the oviduct via a nongenomic path-
way, since such activation occurs when mRNA synthesis is
completely suppressed by α-Amanitin [6]. Estradiol-
induced phosphorylation is essential for its effect on
oocyte transport in cycling rats since local administration
of a broad-spectrum inhibitor of protein kinases totally
blocks the effect of E2 on egg transport [7,8]. Thus, E2
accelerates oviductal egg transport through nongenomic
pathways in cyclic rats, while it does it through genomic
pathways in pregnant rats. Recently, this change in path-
ways has been designated "intracellular path shifting"
(IPS) [9]. Further investigation has shown that activity of
the enzyme Catechol-O-Methyltransferase (COMT) is
higher in the oviduct of cyclic than pregnant rats while
OR486 a selective inhibitor of COMT blocked the effect of
E2 on oviductal egg transport only in cyclic rats suggesting
that decreased activity of oviductal COMT induced by
mating is one of the underlying mechanisms of IPS [9].
Although the physiological relevance of IPS has not been
clearly established it is probable that decrease in the
COMT activity induced by mating in the oviduct protects
the embryos from the deleterious effect that methox-
yestradiols exert during the first stages of development
[10].
Estrogens induce cellular changes in their target organs
through several different mechanisms that involve activa-
tion of estrogen receptors (ER). The two main forms of ER,
ESR1 and ESR2 (formerly known as ER-α and ER-β), have
distinct tissue expression patterns in both humans and
rodents [11]. The antiestrogen ICI 182780 blocks E2-
induced egg transport acceleration in cyclic and pregnant
rats [7] indicating that ER participates in both the
genomic and the nongenomic pathways involved in the
kinetic action of E2 on the oviduct. However, we have
found that levels of ESR1 and ESR2 mRNA and protein in
oviducts of pregnant rats were similar to those oviducts of
cycling rats, suggesting that IPS is not explained by
changes in the expression of ER in the oviduct [12].
Herein, we determined the effect of mating on subcellular
distribution and functionality of ESR1 and ESR2 in the rat
oviduct. First, we compared immunoreactivity of both ER
associated to cell membrane, cytoplasm and nucleus
between epithelial cells of the ampullary and isthmic seg-
ments of cyclic and pregnant rats following treatment
with E2. We also determined the effect of selective ago-
nists for ESR1 (PPT) or ESR2 (DPN) on mRNA levels of
three E2-inducible genes c-fos, brain creatine kinase (Ckb)
and calbindin 9 kDa (s100g) [13,14] in the oviduct of
pregnant and cyclic rats. Additionally, the role of ESR1
and ESR2 on oviductal egg transport was evaluated in
cyclic or pregnant rats treated with PPT or DPN.
Methods
Animals
Sprague-Dawley rats (bred in house) weighing 200-260 g
were used. Animals were kept under controlled tempera-
ture (21-24°C), and lights were on from 0700 to 2100 h.
Water and pelleted food were supplied ad libitum. The
phases of the estrous cycle were determined by daily vagi-
nal smears [15] and all females were used after showing
two consecutive 4-day cycles. Females in pro-estrus were
kept either isolated or caged with fertile males. The fol-
lowing day (estrus) was designated as C1 in the first
instance and day P1 in the second, provided spermatozoa
were found in the vaginal smear. The care and manipula-
tion of the animals was done in accordance with the ethi-
cal guidelines of our institution.
Treatments
Systemic administration of E2
On C1 or P1 E2 5 μg was injected subcutaneously (s.c.) as
a single dose dissolved in 0.1 mL propylene glycol. Con-
trol rats received propylene glycol alone.
Local administration of selective agonist of ESR1 (PPT) or ESR2 
(DPN)
PPT (1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole,
Sigma Chem. CO, St. Louis, MO) [16] or DPN (Diarylpro-
pionitrile, Tocris Cookson Inc. Ellisville, MO) [17] were
injected into each bursa at a concentration of 7.5, 22.5 or
67.5 ng/μL in DMSO 1%. Control rats received the corre-
sponding vehicle alone. Since the range of effective doses
of PPT and DPN given systemically is between 2.5 μg/μL-
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these doses to approximately 1000-fold for local
(intrabursal) injection. To our knowledge these doses of
PPT or DPN did not change the plasmatic E2 and Proges-
terone level in the rat.
Animal surgery and assessment of egg transport
Intrabursal administration of agonists, which minimizes
the dose needed to affect the oviduct without systemic
effects, was performed on C1 or P1 as previously
described [5]. At this time, ovulation has already taken
place, so this treatment cannot affect the number of
oocytes ovulated. Egg transport was evaluated as previ-
ously published [2,4,5]. Twenty-four hours after treat-
ment, animals were sacrificed and their oviducts were
flushed individually with saline. Flushing was examined
under low-power magnification (25×), and the number of
eggs found was recorded.
Real-time PCR
Whole oviducts on C1 (N = 4) or P1 (N = 4) were dis-
sected and flushed to avoid contamination with oocytes
or embryos mRNA. Oviductal RNA was isolated using Tri-
zol Reagent (Invitrogen, Gaithersburg, MD) and 1 μg of
total RNA of each sample was treated with Dnase I Ampli-
fication grade (Invitrogen). The single-strand cDNA was
synthesized by reverse transcription using the Superscript
III Reverse Transcriptase First Strand System for RT-PCR
(Invitrogen), according to the manufacturer's protocol.
The Light Cycler instrument (Roche Diagnostics, GmbH
Mannheim, Germany) was used to quantify the relative
gene expression of c-fos, Ckb or s100g in the oviduct of
cyclic and pregnant rats; Gapdh was chosen as the house-
keeping gene for load control because we have previously
demonstrated that E2  or pregnancy did not affect its
expression [20]. The SYBR® Green I double-strand DNA
binding dye (Roche Diagnostics) was the reagent of
choice for these assays. Primers for c-fos were 5' CCG AGA
TTG CCA ATC TAC TG 3' (sense) and 5' AGA AGG AAC
CAG ACA GGT CC 3' (antisense), Ckb 5' AAG CTG GCA
GTA GAA GCC CT 3' (sense) 5' TTG TCG AAG AGG AAG
TGG TC 3' (antisense), s100g 5' GGC AGC ACT CAC TGA
CAG C 3' (sense) 5' CAG TAG GTG GTG TCG GAG C
3'(antisense) and for Gapdh were 5' ACC ACA GTC CAT
GCC ATC AC 3' (sense) and 5' TCC ACC ACC CTG TTG
CTG TA 3' (antisense). The thermal cycling conditions
included an initial activation step at 95°C for 25 min, fol-
lowed by 40 cycles of denaturizing and annealing-ampli-
fication (95°C for 15 sec, 60°C for 15 sec and 72°C for 30
sec) and finally one cycle of melting (95° to 60°C). To
verify specificity of the product, amplified products were
subject to melting curve analysis as well as electrophore-
sis, and product sequencing was performed to confirm
identity as described by Muscillo et al [21]. The expression
of transcripts was determined using a method previously
reported [22,9].
Immunoelectron microscopy
Oviducts from vehicle and E2-treated rats were separated
into ampulla and isthmus and the excess mucus was
removed in each segment by flushing with 50 μL saline.
Both segments were fixed in 4% freshly depolymerised
paraformaldehyde, 0.5% glutaraldehyde in phosphate
buffer pH 7.4 0.1 M containing saccharose 0.1 M, DMSO
1% and CaCl2 1% for 2-4 h at room temperature. The
fixed samples were washed three times with phosphate
buffer, dehydrated in a graded ethanol series and infil-
trated with LR Gold (Plano, München, FRG). Subse-
quently, the samples were transferred to gelatine capsules
filled with 0.8% (w/v) benzoyl peroxide in LR Gold and
kept for polymerization at a pressure of 500 mmHg. The
blocks were cured for 1-2 days at room temperature before
sectioning with a Sorvall-2000 ultramicrotome using a
diamond knife. The sections (50-80 nm) were mounted
on formvar-coated nickel grids and incubated on droplets
of 0.1 M glycine in PBS pH 7.6, and subsequently blocked
with 1% bovine foetal serum for 2 h at room temperature.
The grids were then incubated for 2 h with a rabbit anti-
ESR1 (MC-20, Santa Cruz Biotechnology, Santa Cruz, CA)
or anti-ESR2 (clone 68-4, Chemicon International, Biller-
ica, MA) at 1:50 dilution. After washing with PBS, the
preparations were incubated for 1 h with goat anti-rabbit
immunoglobulin conjugated to 10 nm gold particles
(Kirkegaard & Perry Laboratories Inc, Gaithersburg, MD)
diluted 1:30. Sections were washed and contrasted with
Reynolds stain [23]. All sections were examined using a
Phillips-TECNAI 12 BIOTWIN EM Microscope (FEI Com-
pany, Hillsboro, OR) at 80 kV. As negative controls the
primary antibody was replaced by rabbit preimmune
serum or oviductal samples without prior incubation with
anti-ESR1 antibody or anti-ESR2 antibody were also
included. For further validation we also performed immu-
noelectron microscopy of the isthmic segment from vehi-
cle and E2-treated rats using a mouse anti-ESR1 from
another company (H-151, Calbiochem, La Jolla, CA), as
primary antibody diluted 1:30. Furthermore, we used
gold-labeled particles of 40 nm (Kirkegaard & Perry Labo-
ratories Inc) to obtain photomicrographs at low magnifi-
cation for show unspecific background labeling in the
oviductal lumen. At least ten areas of 63 μm2 from differ-
ent epithelial cells and different sections of an oviduct
were photographed and the photomicrographs were digi-
talized in an iBook computer (Apple Computer Inc,
Cupertino, CA), and gold particles present only in the
cells were counted using the image analysis software
Adobe Photoshop 7.0 (Adobe Systems Inc, San Jose, CA)
by an observer blinded to the treatment groups. The
results of the immunolabeling are presented as the quo-
tient of the number of gold particles present divided by
the area and cell number inspected [24].Reproductive Biology and Endocrinology 2009, 7:139 http://www.rbej.com/content/7/1/139
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Statistical analysis
The results are presented as mean ± SE. Overall analysis
was done by Kruskal-Wallis test, followed by Mann-Whit-
ney test for pair-wise comparisons when overall signifi-
cance was detected.
Results
Distribution of ESR1 and ESR2 in epithelial cells of mated 
and non-mated rat oviducts treated with E2
At 09:00 h of C1 or P1, 8 rats were injected with E2 5 μg or
vehicle and 3 h later they were sacrificed and their ovi-
ducts were separated into ampulla and isthmus and proc-
essed for immunoelectron microscopy. Representative
photomicrographs of the subcellular distribution of ESR1
and ESR2-reacting gold particles in oviductal epithelial
cells of the rat are shown in Figures 1, 2 and 3. Receptor
immunoreactivity was found associated with the nucleus,
cytoplasm and plasma membrane, including cilia, of the
epithelial cells. Data for subcellular distribution of ESR1
in ampulla and isthmus are shown in Figure 4. Mating
increased the immunoreactivity of ESR1 in the plasma
membrane and cytoplasm of the ampullary segment
although it did not affect the ESR1 immunoreactivity in
the isthmus. In cyclic rats, E2 treatment increased the den-
sity of ESR1 labeling in all three compartments from both
segments, except the nucleus of the isthmic segment,
whereas in pregnant rats a major increase in labeling was
observed only in the cytoplasm of the isthmic segment.
Representative photomicrographs of oviductal epithelial cells processed by immunoelectron microscopy with gold labeled-anti- bodies of 10 nm for ESR1 (a-c) or ESR2 (d-f) Figure 1
Representative photomicrographs of oviductal epithelial cells processed by immunoelectron microscopy with 
gold labeled-antibodies of 10 nm for ESR1 (a-c) or ESR2 (d-f). Ampullary and isthmic sections of cyclic (a-c) and preg-
nant (d-f) rats are shown in the upper and lower panels, respectively. Arrows denotes ESR1-or ESR2 reacting gold particles in 
the epithelial cells. Arowheads emphasize the association of estradiol receptor immunoreactivity with cilia (cl, see insert in d). 
Asterisks indicate unspecific background laleling. Bar: 0.5 μm. PM = plasma membrane, C = cytoplasm, N = nucleus, L = 
lumen, SV = secretory vesicle.
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Representative photomicrographs of oviductal epithelial cells processed by immunoelectron microscopy without prior incuba- tion with anti-ESR1 antibody (a) or anti-ESR2 antibody (b), or incubated with rabbit preimmune serum (c) Figure 2
Representative photomicrographs of oviductal epithelial cells processed by immunoelectron microscopy with-
out prior incubation with anti-ESR1 antibody (a) or anti-ESR2 antibody (b), or incubated with rabbit preim-
mune serum (c). Bar: 0.5 μm. PM = plasma membrane, C = cytoplasm, L = lumen, cl = cilia. Bar: 0.5 μm.
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Representative photomicrographs at low magnification of oviductal epithelial cells processed by immunoelectron microscopy  with gold labelled-antibodies of 40 nm for ESR1 (a) or ESR2 (b) Figure 3
Representative photomicrographs at low magnification of oviductal epithelial cells processed by immunoelec-
tron microscopy with gold labelled-antibodies of 40 nm for ESR1 (a) or ESR2 (b). Arrows denotes ESR1-or ESR2 
reacting gold particles in the epithelial cells. Note scarce unspecific background laleling. Bar: 0.5 μm. PM = plasma membrane, 
C = cytoplasm, L = lumen.
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Mating decreased immunoreactivity of ESR2 in the cyto-
plasm of the ampullary and isthmic segments although it
increased labeling of ESR2 in the plasma membrane of the
isthmus. In cyclic rats, E2 decreased ESR2 density in the
cytoplasm in the ampulla and in the nucleus of the isth-
mus, whereas in pregnant rats, E2 increased the density of
ESR2 labeling in the cytoplasm in the ampulla and
decreased it in the plasma membrane and nucleus in the
isthmus (Figure 5). The results using the mouse anti-ESR1
were similar to those obtained with the rabbit anti-ESR1
(not shown). Furthermore, low unspecific background
labeling of gold particles was found in the lumen of epi-
thelial cells in control experiments without primary anti-
body or incubation with rabbit preimmune serum (see
figures 2 and 3). All this supports the specificity in the rec-
ognition of ER immunoreactivity.
Effect of selective agonist of ESR1 or ESR2 on the level of 
c-fos, Ckb and s100g in the oviduct of pregnant and cycle 
rats
Rats on C1 (N = 4) or P1 (N = 4) were locally treated with
67.5 ng/μL of PPT or DPN and 3 h later oviducts were
excised and their total RNA were processed by RT-PCR
using specific primers for c-fos, Ckb, s100g or Gapdh as
described above. Figure 6 shows that in cyclic rats oviduc-
tal levels of c-fos, Ckb and s100g were similar while in preg-
nant rats levels of Ckb were major than c-fos and s100g.
PPT increased 5-fold and 3-fold the levels of Ckb and c-fos
in cyclic and pregnant rats while s100g was not affected in
both conditions. In cyclic rats, DPN increased 4- and 5-
fold Ckb and c-fos respectively, while in pregnant rats
DPN increased 2.5 fold c-fos and 2-fold s100g.
Mean number of the density of gold particles (X ± SE) observed for ESR1 in the plasma membrane (PM), cytoplasm (C) and  nucleus (N) of epithelial cells of oviductal ampulla (A) and isthmus (I) from rats on day 1 of the cycle or pregnancy, 3 hours  after treatment with oestradiol Figure 4
Mean number of the density of gold particles (X ± SE) observed for ESR1 in the plasma membrane (PM), cyto-
plasm (C) and nucleus (N) of epithelial cells of oviductal ampulla (A) and isthmus (I) from rats on day 1 of the 
cycle or pregnancy, 3 hours after treatment with oestradiol. Means with different letters are significantly different 
from each other within each graph (P < 0.05). a ≠ b ≠ c. Replicas of this experiment are stated in the figure.
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Effect of selective agonist of ESR1 or ESR2 on oviductal 
egg transport in mated and non-mated rats
Rats on C1 or P1 were locally treated with PPT or DPN 7.5,
22.5 or 67.5 ng/μL and 24 h after treatment egg transport
was evaluated in all groups as described above. The mean
number (X ± SE) of eggs recovered from the oviducts of
control or treated groups are shown in figure 7. Intrabur-
sal administration of PPT decreased the number of eggs
recovered from the oviduct in cyclic and pregnant rats
although at lower doses in cyclic rats. Administration of
DPN decreased the number of eggs only in C1, but not in
P1 rats.
Discussion
An important variable that influences E2 actions on its tar-
get cells is the differential distribution of ESR1 and ESR2.
Previous works have reported presence of ESR1 and ESR2
in the epithelium and smooth muscle layers of the amp-
ullary and isthmic segments of the rat oviduct [25,26].
Here, we show for the first time that ESR1 and ESR2 were
found associated to the plasma membrane, cytoplasm
and nucleus of the epithelial cells of both oviductal seg-
ments in the rat. This is in agreement with previous
immunoelectron microscopy studies reporting localiza-
tion of ESR1 in non-nuclear sites in other cell types
[27,28]. Other studies have also shown the presence of
ESR1 and ESR2 in non-nuclear sites of various cell types
using western blot or ligand-blot of subcellular enriched
fractions [29-31]. Ligand activation of ER associated to
cell membrane and cytoplasm can modulate downstream
pathways that induce discrete signaling responses, includ-
ing stimulation of adenylyl cyclase in breast and vascular
tissues [32,33], activation of Ca2+ flux in arterial smooth
muscle [34] or the cascade Src/Ras/ERK [35]. Our findings
provide evidence of the presence of multiple pools of ER
that could initiate genomic and nongenomic responses to
Mean number of the density of gold particles (X ± SE) observed for ESR2 in the plasma membrane (PM), cytoplasm (C) and  nucleus (N) of epithelial cells of oviductal ampulla (A) and isthmus (I) from rats on day 1 of the cycle or pregnancy, 3 hours  after treatment with oestradiol Figure 5
Mean number of the density of gold particles (X ± SE) observed for ESR2 in the plasma membrane (PM), cyto-
plasm (C) and nucleus (N) of epithelial cells of oviductal ampulla (A) and isthmus (I) from rats on day 1 of the 
cycle or pregnancy, 3 hours after treatment with oestradiol. Means with different letters are significantly different 
from each other within each graph (P < 0.05). a ≠ b ≠ c. Replicas of this experiment are stated in the figure.
a a
c
a
aa a a a
c
c
aa a
b a, b
b
aa
bb
Cyclic
Ampulla
Ampulla
Isthmus
Isthmus
V E2
Pregnant
V E2
V E2
V E2
ER-β
N= 9 cells
N= 9 cells
N= 8 cells N= 9 cells
N= 10 cells N= 9 cells
N= 11 cells N= 11 cells
0
5
10
15
20
25
30 PM
C
N
0
5
10
15
20
25
30 PM
C
N
0
5
10
15
20
25
30
PM
C
N
0
5
10
15
20
25
30
PM
C
N
g
o
l
d
p
a
r
t
i
c
l
e
s
/
μ
m
2
/
c
e
l
l
(
X
±
S
E
)
g
o
l
d
p
a
r
t
i
c
l
e
s
/
μ
m
2
/
c
e
l
l
(
X
±
S
E
)
g
o
l
d
p
a
r
t
i
c
l
e
s
/
μ
m
2
/
c
e
l
l
(
X
±
S
E
)
g
o
l
d
p
a
r
t
i
c
l
e
s
/
μ
m
2
/
c
e
l
l
(
X
±
S
E
)Reproductive Biology and Endocrinology 2009, 7:139 http://www.rbej.com/content/7/1/139
Page 8 of 11
(page number not for citation purposes)
E2. Furthermore, the data reported here show a dynamic
behavior of these ER pools in response to mating-associ-
ated signals and to an E2 pulse.
Since mating induces IPS we expected that pregnant and
cyclic rats would exhibit different ER subcellular distribu-
tion, e.g. higher ESR1, ESR2 or both in the nuclear com-
partment. However, quantitative analyses showed that
mating increased the number of both receptors only in the
non-nuclear compartments. Furthermore, when E2 was
administered to pregnant or cyclic rats receptor immuno-
reactivity also accumulated in the non-nuclear compart-
ments. Thus, IPS occurs independently of the changes in
the distribution of ESR1 and ESR2 in the oviductal epithe-
lial cells induced by mating. ESR1 and ESR2 are also
expressed in the mucosa and muscle layer of the rat ovi-
duct [25,26] so that it is possible that mating stimulates
accumulation of ER in the nuclear compartment of other
cell types. The changes described in gold particle density
may reflect either change in antibody accessibility to
immunoreactive epitopes or true changes in the expres-
sion level of ER. The current data does not allow to distin-
guish between these two possibilities but increases up to
ten fold 3 hours after E2 administration seem more plau-
sible as a result of ER dissociation from scaffolding pro-
teins than a result of de novo synthesis. In fact, previously
we have found that levels of ESR1 and ESR2 mRNA and
protein in whole oviducts of pregnant rats were similar to
those in oviducts of cycling rats, suggesting that mating
does not regulate global expression of ER in the oviduct
[12].
We observed different responses in the subcellular distri-
bution of ER in the epithelial cells of the two oviductal
segments. It is known that the relative proportion
between ciliated and secretory epithelial cells varies con-
siderably from ampulla to isthmus [36] so that is proba-
ble that mating-associated signals may have acted
differentially on these two cell types. Further analysis that
segregates the responses of ciliated from secretory epithe-
lial needs to be done. It has been reported that in the rat,
E2 acts only in the isthmic segment to accelerate egg trans-
port [37] while that isthmus-specific apoptosis of epithe-
lial cells and activation of cilia-localized ESR2A induced
by clomiphene citrate act in parallel to block egg transport
[19]. Thus, it is probable that differences in the distribu-
tion of ESR1 and ESR2 between ampulla and isthmus
could reflect specific contribution of these segments to
signals provided by E2 to regulate egg transport. Further-
more, we did not discard the possibility that E2  acts
directly on the smooth muscle cells because it has been
found presence of ESR1 and ESR2 in the myosalpinx of
the rat [25,26].
Interestingly, ESR1 and ESR2 were also observed associ-
ated with the cilia of epithelial cells (see insert in figure
1d). Estradiol regulates differentiation and dedifferentia-
tion of ciliated cells of the mammalian oviduct [38]. Fur-
thermore, follicular fluid of human pre-ovulatory follicles
containing high concentrations of estradiol and progester-
one increased the ciliary beat frequency of human oviduc-
tal ciliated cells [39]. Our findings suggest that E2 could
regulate ciliary activity directly through a nongenomic
mechanism probably involving phosphorylation/dephos-
phorylation of some proteins (e.g. tubulin or dynein)
present in this structure. Recently, it has been shown that
ESR2 is colocalized with β-tubulin at stem portion of the
cilia of the oviductal epithelial cells in immature rats [40].
Additionally, gold particles for ESR1 and ESR2 were found
Mean number of the relative copies (X ± SE) of Ckb, c-fos and  s100g in the rat oviducts on day 1 of cycle or pregnancy fol- lowing intrabursal treatments with the selective agonists of  ESR1, PPT or ESR2, DPN Figure 6
Mean number of the relative copies (X ± SE) of Ckb, 
c-fos and s100g in the rat oviducts on day 1 of cycle or 
pregnancy following intrabursal treatments with the 
selective agonists of ESR1, PPT or ESR2, DPN. V: 
vehicle of drugs, PPT: 67.5 ng/μL, DPN: 67.5 ng/μL. All treat-
ments were given 3 h before autopsy. Each experiment con-
sisted of 4 replicas. Means with different letters are 
significantly different from each other (P < 0.05), a ≠ b ≠ c ≠ 
d.
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associated to secretory vesicles. This corroborates previous
works reporting localization of ESR1 and ER2 in the rough
endoplasmic reticulum and secretory vesicles of the
female rat pituitary cells [41]. Although, the biological sig-
nificance of the localization of ESR1 and ESR2 in secretory
vesicles remains to be determined it is probable that a
Golgi-dependent pathway could exist for translation of ER
that could be translocated into the plasma membrane and
mediate nongenomic responses [41].
In other estrogen-sensitive tissues ER subtype expression
is differentially regulated by E2. In the human vena cava,
E2 down-regulates ESR1 expression [42] while deprivation
of E2 in the cerebral microvessels of ovariectomized rats is
associated with a decrease in the expression of both iso-
forms and E2 replacement up-regulates ESR1 but does not
affect expression of ESR2 [43]. In ovine endothelial cells,
short-term treatment with E2 down-regulates ESR1, but
not ESR2 while long-term treatment up-regulates ESR1
and down-regulates ESR2 expression [44]. Our findings
provide the first evidence that E2 is able to differentially
regulate not just the expression level, but also the subcel-
lular distribution of ESR1 and ESR2 in a target cell. We
also observed different responses in the expression of
three E2-associated signaling genes, c-fos, Ckb and s100g,
in the oviduct of pregnant and cyclic rats when ESR1 or
ESR2 was activated. Moreover, activation of ESR1 or ESR2
increased expression of c-fos  although mating only
blunted the effect of ESR2. This indicates that mating-
associated signals modulate intraoviductal signalling of
both ER providing evidence that mating may change the
functional role of these receptors in the rat oviduct. On
Mean number of eggs (X ± SE) recovered from rat oviducts on day 2 of the cycle or pregnancy, 24 h after intrabursal treatment  with different doses of the selective agonists of ESR1, PPT or ESR2, DPN Figure 7
Mean number of eggs (X ± SE) recovered from rat oviducts on day 2 of the cycle or pregnancy, 24 h after 
intrabursal treatment with different doses of the selective agonists of ESR1, PPT or ESR2, DPN. Figures inside 
the bars indicate the number of animals used. Means with different letters are significantly different from each other within 
each graph, a ≠ b ≠ c (P < 0.05).
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the other hand, the role of c-fos,  Ckb  or  s100g  on IPS
induction or E2-induced egg transport acceleration needs
to be disclosed.
Given that PPT is 400-fold more selective and DPN is only
70-fold more selective for ESR1 an ESR2 respectively, it
was not surprisingly that PPT would be more effective to
accelerate oviductal egg transport than DPN in cyclic rats.
However, mating decreased effectiveness of PPT and
blocked the effect of DPN. Probably, the nongenomic
pathway by which E2 accelerates egg transport operates
through activation of either ESR1 and ESR2 while the
genomic pathway only operates through ESR1. The fact
that IPS is associated with suppression of ESR2 involve-
ment in the kinetic effect of E2 in the oviduct indicate that
mating exerts a profound influence on the biology of ER
in a target organ of E2 that merits further investigation.
Shao et al [19] have reported that subcutaneous adminis-
tration of DPN retard egg transport in the rat. In this
study, immature animals were treated, prior to DPN
administration, with gonatrophins to mimic the endog-
enous luteneizing hormone surge. Probably, this treat-
ment could have affected the response of the oviduct to
DPN. Another factor is that we recorded the number and
distribution of eggs in the genital tract within the first 24
h after treatment. In order to detect whether PPT or DPN
delay egg transport autopsies should be performed on day
4 or 5 of cycle or pregnancy respectively, but this was not
done.
Conclusion
Estrogen receptors ESR1 and ESR2 present a subcellular
distribution in oviductal epithelial cells that is compatible
with genomic and nongenomic actions of E2 in the rat ovi-
duct. Mating is associated with changes in the basal and
E2-induced subcellular distribution of ESR1 and ESR2 in
these cells although it did not clearly explain IPS. Further-
more, mating affected signaling of both ER in the oviduct
and induced loss of functional involvement of ESR2 on
E2-induced accelerated egg transport. These findings
reveal a profound influence on the intraoviductal ER sig-
nalling pathways exerted by mating.
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